The "Restore Protections for Dialysis Patients Act" amends the Social Security Act to prevent health plans from discriminating against dialysis patients and unfairly shifting their healthcare costs to Medicare.
Mike Kelly
Representative
PA-16
The "Restore Protections for Dialysis Patients Act" amends the Social Security Act to reinforce protections for patients with End-Stage Renal Disease (ESRD) under the Medicare Secondary Payer Act. It prevents health plans from discriminating against ESRD patients or making Medicare the primary payer for their healthcare costs. The act clarifies that dialysis services should not be singled out for unfavorable treatment or coverage limits compared to other medical services, while allowing plans to manage their dialysis provider networks.
This bill, officially titled the "Restore Protections for Dialysis Patients Act," aims to clarify the rules for private health insurance plans covering individuals with End-Stage Renal Disease (ESRD) – that's permanent kidney failure requiring dialysis or a transplant. The core purpose is ensuring these private group health plans fulfill their role as the primary payer before Medicare is billed, and preventing them from discriminating against ESRD patients or treating dialysis less favorably than other medical services. It essentially strengthens existing patient safeguards under the Medicare Secondary Payer Act (MSPA).
So, what's the practical issue this bill addresses? When someone has ESRD and is also covered by a group health plan (like through an employer), that plan is generally supposed to pay first for their healthcare, with Medicare covering secondary costs. This legislation reinforces that requirement, aiming to prevent plans from sidestepping this responsibility and pushing costs onto Medicare prematurely. Section 3 specifically amends the Social Security Act to prohibit plans from designing benefits or applying limitations that disproportionately harm ESRD patients or treat their necessary dialysis differently than other covered medical needs. For instance, a plan shouldn't be able to impose significantly higher co-pays or stricter limits just for dialysis compared to other ongoing treatments like chemotherapy or specialized therapies.
There's a key clarification included in Section 3 that's worth noting. While the bill mandates non-discrimination in benefits and coverage levels, it explicitly states that health plans are not required to include any specific dialysis provider, or even a minimum number of them, within their network. What does this mean in the real world? Your insurance must cover your dialysis fairly based on the plan's terms, but you'll likely still need to use a provider that's in-network to minimize your out-of-pocket expenses. Depending on your plan's network density, this could potentially limit your choice of dialysis centers.
Think of this bill as reinforcing the guardrails for ESRD patients covered by private group health insurance. It underscores the 'payer hierarchy' – private plan first, Medicare second – and explicitly forbids discriminatory practices against dialysis care within benefit structures. However, the freedom plans retain in constructing their provider networks means patients still need to be diligent about confirming which dialysis facilities are covered under their specific insurance plan.